8-K Announcements
6Material company update
May 6, 2026·SEC
Material company update
Apr 1, 2026·SEC
Material company update
Mar 6, 2026·SEC
Clover Health Investments, Corp.(CLOV)Earnings, Financials & Key Ratios
CLOV•NASDAQ•Insurance & Managed Care
Price updated Jun 19, 2026
AboutClover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.Show more
- Revenue$1.92B+40.3%
- Combined Ratio104.44%+1.1%
- Net Income-$86M-98.9%
- Return on Equity-26.33%-92.1%
- Medical Cost Ratio81.5%+11.1%
- Operating Margin-4.44%-33.2%
- Net Margin-4.45%-41.7%
- ROA-15.25%-104.2%
- Equity / Assets57.06%-2.9%
CLOV Key Insights
Clover Health Investments, Corp. (CLOV) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Momentum leader: RS Rating 96 (top 4%)
- ✓Trading near 52-week high
✗Weaknesses
- ✗Weak Piotroski F-Score: 2/9
- ✗High loss ratio of 81.5%
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when CLOV posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
CLOV Price & Volume
Clover Health Investments, Corp. (CLOV) stock price & volume — 10-year historical chart
Loading chart...
CLOV Growth Metrics
Clover Health Investments, Corp. (CLOV) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years23.39%
3 Years20.62%
TTM48.41%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-126.74%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-100%
Return on Capital
10 Years-99.35%
5 Years-68.96%
3 Years-32.59%
Last Year-24.46%
CLOV Recent Earnings
Clover Health Investments, Corp. (CLOV) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
May 6, 2026Metric
Actual
Est
EPS
$0.07+0.0%
$0.07
Rev
$749M+4.8%
$715M
Q1 2026
Feb 26, 2026Metric
Actual
Est
EPS
$0.05+51.0%
$0.10
Rev
$488M+4.4%
$467M
Q4 2025
Nov 4, 2025Metric
Actual
Est
EPS
$0.05-350.0%
$0.02
Rev
$497M+6.3%
$467M
Q3 2025
Aug 5, 2025Metric
Actual
Est
EPS
$0.03+0.0%
$0.03
Rev
$478M+2.0%
$468M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $0.07vs $0.07+0.0% | $749Mvs $715M+4.8% |
| Q1 2026 | Feb 26, 2026 | $0.05vs $0.10+51.0% | $488Mvs $467M+4.4% |
| Q4 2025 | Nov 4, 2025 | $0.05vs $0.02-350.0% | $497Mvs $467M+6.3% |
| Q3 2025 | Aug 5, 2025 | $0.03vs $0.03+0.0% | $478Mvs $468M+2.0% |
Based on last 12 quarters of dataView full earnings history →
CLOV Peer Comparison
Clover Health Investments, Corp. (CLOV) competitors in Tech-Enabled Health Plans — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 HUM | 43.3B | 360.65 | 36.65 | 10.06% | 0.82% | 6.17% | 0.73 | |
 CVS | 125.45B | 98.32 | 70.73 | 7.85% | 0.72% | 3.86% | 1.24 | |
 ELV | 84.37B | 388.50 | 15.47 | 12.62% | 2.62% | 11.92% | 0.75 | |
 CNC | 30.13B | 61.02 | -4.48 | 19.44% | -3.25% | -28.6% | 0.94 | |
 MOH | 10.18B | 195.37 | 21.90 | 11.75% | 0.42% | 4.44% | 0.97 | |
 ALHC | 4.47B | 21.86 | -5908.11 | 46.06% | 0.47% | 11.5% | 1.89 | |
 OSCR | 7.36B | 28.40 | -16.80 | 27.5% | -0.3% | -3.26% | 0.44 | |
 BHVN | 1.44B | 13.57 | -1.98 | -8.66% | 5.36 |
Compare CLOV vs Peers
Clover Health Investments, Corp. (CLOV) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CLOV Income Statement
Clover Health Investments, Corp. (CLOV) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Revenue | 281.02M | 462.27M | 672.89M | 1.47B | 1.1B | 1.26B | 1.37B | 1.92B | 2.21B |
Revenue Growth % | - | 64.49% | 45.56% | 118.76% | -25.51% | 14.96% | 8.77% | 40.34% | 48.41% |
Medical Costs & Claims | 0 | 449.7M | 590.08M | 1.55B | 993.07M | 1B | 1.01B | 1.57B | 1.8B |
Medical Cost Ratio % | 0% | 97.28% | 87.69% | 105.38% | 90.56% | 79.7% | 73.39% | 81.5% | 81.8% |
Gross Profit | 281.02M▲ 0% | 12.56M▼ 95.5% | 82.81M▲ 559.0% | -79.18M▼ 195.6% | 103.48M▲ 230.7% | 255.95M▲ 147.3% | 364.8M▲ 42.5% | 355.88M▼ 2.4% | 401.55M▲ 0% |
Gross Margin % | 100% | 2.72% | 12.31% | -5.38% | 9.44% | 20.3% | 26.61% | 18.49% | 18.2% |
Gross Profit Growth % | - | -95.53% | 559.02% | -195.62% | 230.68% | 147.35% | 42.53% | -2.45% | - |
Operating Expenses | 476M | 195.76M | 175.51M | 557.81M | 390.14M | 461.28M | 410.55M | 441.43M | 463.48M |
OpEx / Revenue % | 169.38% | 42.35% | 26.08% | 37.89% | 35.58% | 36.59% | 29.94% | 22.94% | 21.01% |
Depreciation & Amortization | 185.8M | 551K | 555K | 1.25M | 1.19M | 2.51M | 1.33M | 1.69M | 1.74M |
Combined Ratio % | 169.38% | 139.63% | 113.78% | 143.27% | 126.14% | 116.29% | 103.34% | 104.44% | 102.81% |
Operating Income | -185.8M▲ 0% | -183.2M▲ 1.4% | -92.71M▲ 49.4% | -636.99M▼ 587.1% | -286.66M▲ 55.0% | -205.33M▲ 28.4% | -45.75M▲ 77.7% | -85.53M▼ 87.0% | -61.92M▲ 0% |
Operating Margin % | -66.11% | -39.63% | -13.78% | -43.27% | -26.14% | -16.29% | -3.34% | -4.44% | -2.81% |
Operating Income Growth % | - | 1.4% | 49.4% | -587.1% | 55% | 28.37% | 77.72% | -86.95% | - |
EBITDA | 0 | -182.65M | -92.15M | -635.75M | -285.48M | -202.82M | -44.42M | -83.84M | -60.19M |
EBITDA Margin % | 0% | -39.51% | -13.69% | -43.19% | -26.03% | -16.09% | -3.24% | -4.36% | -2.73% |
Interest Expense | 0 | 39.07M | 57.11M | 16.91M | 1.36M | 7K | 0 | 0 | 0 |
Non-Operating Income | 186.67M | 141.47M | -13.42M | -66.15M | -33.44M | 4.81M | 517K | 20K | -4.98M |
Pretax Income | -201.93M▲ 0% | -363.74M▼ 80.1% | -136.39M▲ 62.5% | -587.76M▼ 330.9% | -254.58M▲ 56.7% | -210.15M▲ 17.5% | -46.27M▲ 78.0% | -85.55M▼ 84.9% | -56.94M▲ 0% |
Pretax Margin % | -71.85% | -78.69% | -20.27% | -39.93% | -23.22% | -16.67% | -3.37% | -4.45% | -2.58% |
Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Net Income | -201.93M▲ 0% | -363.74M▼ 80.1% | -136.39M▲ 62.5% | -587.76M▼ 330.9% | -339.57M▲ 42.2% | -213.36M▲ 37.2% | -43.01M▲ 79.8% | -85.55M▼ 98.9% | -56.94M▲ 0% |
Net Margin % | -71.85% | -78.69% | -20.27% | -39.93% | -30.97% | -16.93% | -3.14% | -4.45% | -2.58% |
Net Income Growth % | - | -80.13% | 62.5% | -330.93% | 42.23% | 37.17% | 79.84% | -98.91% | -126.74% |
EPS (Diluted) | -4.81▲ 0% | -0.90▲ 81.3% | -0.23▲ 74.4% | -1.25▼ 443.5% | -0.71▲ 43.2% | -0.45▲ 36.6% | -0.09▲ 80.5% | -0.17▼ 93.6% | -0.11▲ 0% |
EPS Growth % | - | 81.29% | 74.44% | -443.48% | 43.2% | 36.62% | 80.49% | -93.62% | -100% |
EPS (Basic) | -4.81 | -0.90 | -0.23 | -1.25 | -0.71 | -0.45 | -0.09 | -0.17 | - |
Diluted Shares Outstanding | 42.01M | 404.44M | 404.44M | 470.85M | 476.24M | 482.18M | 490.02M | 517.24M | 522.18M |
CLOV Balance Sheet
Clover Health Investments, Corp. (CLOV) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Total Assets | 210.6M | 100.35K | 267.25M | 950.8M | 808.62M | 570.67M | 580.74M | 541.01M | 697.73M |
Asset Growth % | - | -99.95% | 266230.5% | 255.77% | -14.95% | -29.43% | 1.76% | -6.84% | -16.32% |
Total Investment Assets | 0 | 0 | 58.76M | 491.23M | 369.08M | 240.82M | 228.72M | 204.14M | 4M |
Long-Term Investments | 0 | 0 | 54.39M | 175.94M | 138.11M | 121M | 201.72M | 187.09M | 757.87M |
Short-Term Investments | 0 | 0 | 4.36M | 315.29M | 230.97M | 119.82M | 27M | 17.05M | 4.29M |
Total Current Assets | 75.4M | 0 | 189.78M | 752.55M | 625M | 427.97M | 343.12M | 307.86M | 448.02M |
Cash & Equivalents | 75.4M | 0 | 92.35M | 299.97M | 103.79M | 116.41M | 194.54M | 78.3M | 173.26M |
Receivables | 0 | 0 | 84.94M | 109.42M | 167.54M | 86.24M | 92.79M | 158.74M | 596.29M |
Other Current Assets | 0 | 0 | 299K | 13.18M | 104.55M | 91.08M | 15.62M | 53.77M | 67.77M |
Goodwill & Intangibles | 2.99M | 0 | 4.23M | 4.23M | 20M | 2.99M | 2.99M | 2.99M | 11.96M |
Goodwill | 0 | 0 | 0 | 0 | 11.75M | 0 | 0 | 0 | 0 |
Intangible Assets | 2.99M | 0 | 4.23M | 4.23M | 8.25M | 2.99M | 2.99M | 2.99M | 2.99M |
PP&E (Net) | 3.21M | 0 | 9.96M | 7.65M | 9.78M | 5.08M | 5.31M | 6.38M | 6.9M |
Other Assets | 128.99M | 100.35K | 8.88M | 10.43M | 15.73M | 13.63M | 27.6M | 36.69M | 37.57M |
Total Liabilities | 265.42M | 117.98K | 880.45M | 411.49M | 451.73M | 284.28M | 239.6M | 232.31M | 358.3M |
Total Debt | 49.25M | 0 | 138.36M | 27.83M | 5.86M | 4.66M | 0 | 0 | 0 |
Net Debt | -26.15M | 0 | 46.01M | -272.14M | -97.93M | -111.74M | -194.54M | -78.3M | -173.26M |
Long-Term Debt | 49.25M | 0 | 106.41M | 19.94M | 0 | 0 | 0 | 0 | 0 |
Short-Term Debt | 0 | 0 | 20.8M | 0 | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 6.03M | 117.98K | 164.23M | 372.62M | 431.51M | 261.12M | 213.52M | 208.82M | 336.58M |
Accounts Payable | 0 | 0 | 30.67M | 28.13M | 32.45M | 37.18M | 34.56M | 153.25M | 260.42M |
Deferred Revenue | 0 | 0 | 102.43M | 138.6M | 0 | 3.1M | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | -102.42M | 8.99M | 81.57M | 61.12M | 22.56M | 55.57M | 76.17M |
Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Liabilities | 210.15M | 0 | 603.46M | 14.1M | 16.19M | 20.16M | 26.08M | 23.48M | 21.72M |
Total Equity | -54.83M▲ 0% | -17.63K▲ 100.0% | -613.19M▼ 3477825.2% | 539.32M▲ 188.0% | 356.89M▼ 33.8% | 286.39M▼ 19.8% | 341.14M▲ 19.1% | 308.7M▼ 9.5% | 339.43M▲ 0% |
Equity Growth % | - | 99.97% | -3477825.25% | 187.95% | -33.83% | -19.75% | 19.12% | -9.51% | -2.93% |
Shareholders Equity | -54.83M | -17.63K | -617.1M | 535.41M | 356.89M | 286.39M | 341.14M | 308.7M | 339.43M |
Minority Interest | 0 | 0 | 3.9M | 3.9M | 0 | 0 | 0 | 0 | 0 |
Retained Earnings | -527.9M | -17.63K | -1.03B | -1.62B | -1.95B | -2.16B | -2.2B | -2.29B | -2.26B |
Common Stock | 4K | 0 | 9K | 46K | 46K | 49K | 50K | 52K | 52K |
Accumulated OCI | 0 | 0 | 10K | -1.93M | -9.37M | -2.37M | -1.58M | 528K | -672K |
Return on Equity (ROE) | - | - | - | -108.98% | -75.78% | -66.34% | -13.71% | -26.33% | -17.08% |
Return on Assets (ROA) | -95.88% | -345.27% | -102.03% | -96.51% | -38.6% | -30.94% | -7.47% | -15.25% | -9.6% |
Equity / Assets | -26.03% | -17.57% | -229.44% | 56.72% | 44.14% | 50.19% | 58.74% | 57.06% | 48.65% |
Debt / Equity | - | - | - | 0.05x | 0.02x | 0.02x | - | - | 0.00x |
Book Value per Share | -1.31 | -0.00 | -1.52 | 1.15 | 0.75 | 0.59 | 0.70 | 0.60 | 0.65 |
Tangible BV per Share | -1.38 | -0.00 | -1.53 | 1.14 | 0.71 | 0.59 | 0.69 | 0.59 | 0.64 |
CLOV Cash Flow Statement
Clover Health Investments, Corp. (CLOV) cash flow — operating, investing & free cash flow history
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -153.28M | -159.88M | -118.5M | -282.33M | -203.93M | -115.87M | 34.84M | -66.93M | 57.25M |
Operating CF Growth % | - | -4.3% | 25.88% | -138.25% | 27.77% | 43.18% | 130.07% | -292.09% | 619.11% |
Operating CF / Revenue % | -54.54% | -34.59% | -17.61% | -19.18% | -18.6% | -9.19% | 2.54% | -3.48% | 2.6% |
Net Income | -201.93M | -363.74M | -136.39M | -587.76M | -339.57M | -213.36M | -43.01M | -85.55M | -56.94M |
Depreciation & Amortization | 487K | 551K | 0 | 1.25M | 1.19M | 2.51M | 1.33M | 1.69M | 1.22M |
Stock-Based Compensation | 3.68M | 3.3M | 0 | 163.72M | 164.31M | 140.93M | 114.33M | 103.66M | 77.22M |
Deferred Taxes | 0 | 0 | 0 | -66.09M | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 9.51M | 167.7M | 42.35M | 13.88M | -27.49M | 9.48M | -50.66M | -2.53M | 18.51M |
Working Capital Changes | 34.97M | 32.31M | -24.46M | 192.67M | -2.36M | -55.43M | 12.86M | -84.2M | 17.24M |
Cash from Investing | 97.53M | -181.91M | 141.31M | -435.45M | 95.13M | 140.01M | 565K | 4.08M | -9.92M |
Capital Expenditures | -1.48M | -23K | -693K | -723K | -4.47M | -584K | -1.56M | -2.04M | -2.71M |
Acquisitions | 0 | -1.18M | 3.9M | 434.72M | -16.2M | 0 | 0 | 0 | 0 |
Purchase of Investments | 0 | -505.55M | -174.32M | -876.25M | -369.65M | -175.57M | -201.24M | -205.1M | -212.84M |
Sale/Maturity of Investments | 0 | 324.84M | 312.42M | 441.53M | 485.45M | 316.16M | 203.36M | 211.22M | 205.63M |
Other Investing | 99M | 0 | 0 | -434.72M | 0 | 0 | 0 | 0 | 0 |
Cash from Financing | 74.59M | 333.98M | 1.94M | 925.39M | -4.96M | -33.86M | -17.36M | -53.38M | -29.51M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | -147K | -6.36M | -6.22M | -18.26M | -55.2M | -31.14M |
Stock Issued | 0 | 601K | 1.75M | 289.92M | 1.4M | 1.15M | 902K | 1.81M | 1.63M |
Debt Issuance (Net) | 1000K | 1000K | 1000K | -1000K | 0 | 0 | 0 | 0 | 0 |
Other Financing | 44.83M | -363K | -957K | 666.55M | 0 | -28.79M | 0 | 0 | 0 |
Net Change in Cash | 18.83M▲ 0% | -7.8M▼ 141.4% | 92.35M▲ 1283.2% | 207.62M▲ 124.8% | -113.75M▼ 154.8% | -9.72M▲ 91.5% | 18.05M▲ 285.7% | -116.24M▼ 744.0% | 17.83M▲ 0% |
Exchange Rate Effect | 0 | 0 | 67.6M | 0 | 0 | 0 | 0 | 0 | 0 |
Cash at Beginning | 56.57M | 75.4M | 0 | 92.35M | 299.97M | 186.21M | 176.49M | 194.54M | 78.3M |
Cash at End | 75.4M | 67.6M | 92.35M | 299.97M | 186.21M | 176.49M | 194.54M | 78.3M | 173.26M |
Free Cash Flow | -154.76M▲ 0% | -159.9M▼ 3.3% | -119.19M▲ 25.5% | -283.05M▼ 137.5% | -208.39M▲ 26.4% | -116.45M▲ 44.1% | 33.29M▲ 128.6% | -68.98M▼ 307.2% | 54.54M▲ 0% |
FCF Growth % | - | -3.32% | 25.46% | -137.48% | 26.38% | 44.12% | 128.59% | -307.21% | 728.44% |
FCF Margin % | -55.07% | -34.59% | -17.71% | -19.23% | -19% | -9.24% | 2.43% | -3.58% | 2.47% |
FCF per Share | -3.68 | -0.4 | -0.29 | -0.6 | -0.44 | -0.24 | 0.07 | -0.13 | 0.1 |
CLOV Key Ratios
Clover Health Investments, Corp. (CLOV) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
Combined Ratio | 139.63% | 113.78% | 143.27% | 126.14% | 116.29% | 103.34% | 104.44% | 102.81% |
Medical Cost Ratio | 97.28% | 87.69% | 105.38% | 90.56% | 79.7% | 73.39% | 81.5% | 81.8% |
Return on Equity (ROE) | - | - | -108.98% | -75.78% | -66.34% | -13.71% | -26.33% | -17.08% |
Return on Assets (ROA) | -345.27% | -102.03% | -96.51% | -38.6% | -30.94% | -7.47% | -15.25% | -9.6% |
Equity / Assets | -17.57% | -229.44% | 56.72% | 44.14% | 50.19% | 58.74% | 57.06% | 48.65% |
Book Value / Share | -0 | -1.52 | 1.15 | 0.75 | 0.59 | 0.7 | 0.6 | 0.65 |
Debt / Equity | - | - | 0.05x | 0.02x | 0.02x | - | - | 0.00x |
Revenue Growth | 64.49% | 45.56% | 118.76% | -25.51% | 14.96% | 8.77% | 40.34% | 48.41% |
Related:CLOV Dividend History·CLOV Revenue History·CLOV Price History·CLOV P/E History·CLOV Financial Ratios·CLOV Institutional Holders
CLOV SEC Filings & Documents
Clover Health Investments, Corp. (CLOV) SEC filings — annual & quarterly reports (10-K, 10-Q)
CLOV Frequently Asked Questions
Clover Health Investments, Corp. (CLOV) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Clover Health Investments, Corp. (CLOV) grew revenue by 40.3% over the past year. This is strong growth.
Clover Health Investments, Corp. (CLOV) reported a net loss of $56.9M for fiscal year 2025.
Dividend & Returns
Clover Health Investments, Corp. (CLOV) has a return on equity (ROE) of -26.3%. Negative ROE indicates the company is unprofitable.
Industry Metrics
Clover Health Investments, Corp. (CLOV) has a combined ratio of 104.4%. A ratio above 100% means claims and expenses exceed premiums.